| First Author | Lagarrigue F | Year | 2022 |
| Journal | J Immunol | Volume | 208 |
| Issue | 6 | Pages | 1378-1388 |
| PubMed ID | 35197328 | Mgi Jnum | J:322712 |
| Mgi Id | MGI:7257990 | Doi | 10.4049/jimmunol.2100843 |
| Citation | Lagarrigue F, et al. (2022) Direct Binding of Rap1 to Talin1 and to MRL Proteins Promotes Integrin Activation in CD4(+) T Cells. J Immunol 208(6):1378-1388 |
| abstractText | Agonist-induced Rap1 GTP loading results in integrin activation involved in T cell trafficking and functions. MRL proteins Rap1-interacting adapter molecule (RIAM) and lamellipodin (LPD) are Rap1 effectors that can recruit talin1 to integrins, resulting in integrin activation. Recent work also implicates direct Rap1-talin1 interaction in integrin activation. Here, we analyze in mice the connections between Rap1 and talin1 that support integrin activation in conventional CD4(+) T (Tconv) and CD25(Hi)Foxp3(+)CD4(+) regulatory T (Treg) cells. Talin1(R35E, R118E) mutation that disrupts both Rap1 binding sites results in a partial defect in alphaLbeta2, alpha4beta1, and alpha4beta7 integrin activation in both Tconv and Treg cells with resulting defects in T cell homing. Talin1(R35E,R118E) Tconv manifested reduced capacity to induce colitis in an adoptive transfer mouse model. Loss of RIAM exacerbates the defects in Treg cell function caused by the talin1(R35E,R118E) mutation, and deleting both MRL proteins in combination with talin1(R35E,R118E) phenocopy the complete lack of integrin activation observed in Rap1a/b-null Treg cells. In sum, these data reveal the functionally significant connections between Rap1 and talin1 that enable alphaLbeta2, alpha4beta1, and alpha4beta7 integrin activation in CD4(+) T cells. |
